Ads
related to: colon cancer screening test options for menmyriad.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.
Colorectal cancer screening options include at-home stool-sample tests, which are more convenient for patients. Despite these alternatives, colonoscopy remains the most effective method.
The test would need to be given at least every three years, starting at age 45 — the same age it's recommended to begin colorectal screening. A positive test isn’t necessarily a diagnosis.
Screening for colorectal cancer, if done early enough, is preventive, seeing as benign lumps called polyps in the colon and rectum are the start to almost all cases of colon cancer. These polyps can be identified and removed by screening tests like a colonoscopy , in which the whole colon is visible.
The M2-PK Test is a non-invasive screening method for the early detection of colorectal cancers and polyps which are known to be the precursors of colorectal cancer. The M2-PK Test which is used for stool analysis is available either as fully quantitative ELISA Test or as a rapid test that can be performed by any general practitioner without the need of a laboratory or any additional equipment.
Shield can help improve colorectal cancer screening rates so we can detect more cancers at an early stage, when they are treatable," AmirAli Talasaz, Guardant Health co-CEO, said in a press release.
Ads
related to: colon cancer screening test options for menmyriad.com has been visited by 10K+ users in the past month